Glass House Brands (GLAS) Profit After Tax (2020 - 2026)
Glass House Brands' (GLAS) quarterly Profit After Tax came in at -$17.0 million in Q1 2026, down 4.67% on a QoQ basis from -$16.2 million in Q4 2025.
Glass House Brands (GLAS) Profit After Tax (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Profit After Tax data on file, last reported at -$17.0 million in Q1 2026.
- On a quarterly basis, Profit After Tax changed N/A year-over-year to -$17.0 million in Q1 2026; TTM through Mar 2026 was -$36.7 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$29.7 million, down 4219.28% from the prior year.
- Profit After Tax for Q1 2026 stood at -$17.0 million, down from -$16.2 million in the prior quarter.
- Over the last five years, Profit After Tax for GLAS reached as high as $38.1 million in Q4 2023 and fell as low as -$24.9 million in Q2 2023.
- Historically, Profit After Tax has averaged $1.2 million across 5 years, with a median of -$210472.0 in 2023.
- On a YoY basis, Profit After Tax climbed as much as 296.28% in 2022 and fell as far as 400.87% in 2022.
- Year by year, Profit After Tax stood at $14.4 million in 2022, then soared by 164.38% to $38.1 million in 2023, then tumbled by 73.66% to $10.0 million in 2024, then sank by 261.85% to -$16.2 million in 2025, then decreased by 4.67% to -$17.0 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$17.0 million in Q1 2026, -$16.2 million in Q4 2025, and -$12.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | -17.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.01 Mn |
| Dec 31, 2025 | -16.25 Mn |
| Sep 30, 2025 | -12.19 Mn |
| Jun 30, 2025 | 8.74 Mn |
| Jun 30, 2024 | 10.04 Mn |
| Dec 31, 2023 | 38.12 Mn |
| Sep 30, 2023 | -210,472.00 |
| Jun 30, 2023 | -24.91 Mn |
| Mar 31, 2023 | 34.78 Mn |
| Dec 31, 2022 | 14.42 Mn |
| Sep 30, 2022 | 15.17 Mn |
| Jun 30, 2022 | -14.19 Mn |
| Mar 31, 2022 | -20.41 Mn |
| Dec 31, 2021 | -18.77 Mn |
| Sep 30, 2021 | -7.73 Mn |
| Jun 30, 2021 | 4.72 Mn |
| Mar 31, 2021 | 13.15 Mn |
| Dec 31, 2020 | -4,059.25 Bn |
| Sep 30, 2020 | -3.80 Mn |
| Mar 31, 2020 | 5.14 Mn |